Inventor · disambiguated record
Matthias Gerlach
Also filed as: GERLACH MATTHIAS
35 granted patents·7 pending applications·169 citations·filing 2000–2018
96Inventor score
Top patents by PatentIndex Score
42 records- 0189US7153873B2Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-aminesGRUENENTHAL GMBH·Filed 2006·Granted Dec 26, 2006·13 cites·32 claims
- 0289US6638933B2Bicyclic imidazo-3-yl-amine derivativesGRUENENTHAL GMBH·Filed 2002·Granted Oct 28, 2003·40 cites·12 claims
- 0387US6657064B2Bicyclic imidazo-5-yl-amine derivativesGRUENENTHAL GMBH·Filed 2002·Granted Dec 2, 2003·26 cites·18 claims
- 0484US8202883B2Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinasesGERLACH MATTHIAS·Filed 2008·Granted Jun 19, 2012·6 cites·24 claims
- 0580US7087607B2Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-aminesGRUENENTHAL GMBH·Filed 2002·Granted Aug 8, 2006·12 cites·32 claims
- 0678US6703404B2Tert -butyl-(7-methyl-imidazol [1,2-a]pyridin-3-yl)-amine derivativesGRUENENTHAL GMBH·Filed 2002·Granted Mar 9, 2004·11 cites·21 claims
- 0775US7211588B2N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparationZENTARIS GMBH·Filed 2004·Granted May 1, 2007·7 cites·12 claims
- 0875US7205299B2Indole derivatives having an apoptosis-inducing effectZENTARIS GMBH·Filed 2004·Granted Apr 17, 2007·7 cites·21 claims
- 0974US6849642B2Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ringGRUENENTHAL GMBH·Filed 2002·Granted Feb 1, 2005·8 cites·13 claims
- 1073US8791118B2Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitorsGERLACH MATTHIAS·Filed 2012·Granted Jul 29, 2014·3 cites·10 claims
- 1172US6936631B2Bicyclic imidazo-5-yl-amine derivativesGRUENENTHAL GMBH·Filed 2003·Granted Aug 30, 2005·5 cites·18 claims
- 1271US8536332B2Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazinesGERLACH MATTHIAS·Filed 2012·Granted Sep 17, 2013·1 cites·25 claims
- 1371US7135568B2Substituted pyrazolopyrimidines and thiazolopyrimidinesGRUENENTHAL GMBH·Filed 2003·Granted Nov 14, 2006·11 cites·37 claims
- 1471US6699877B2Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivativesGRUENENTHAL GMBH·Filed 2002·Granted Mar 2, 2004·7 cites·62 claims
- 1567US8067456B2Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)PAULINI KLAUS·Filed 2008·Granted Nov 29, 2011·2 cites·9 claims
- 1667US7091220B2Substituted indole Mannich basesGRUENENTHAL GMBH·Filed 2000·Granted Aug 15, 2006·3 cites·98 claims
- 1767US7034018B2Substituted pyrrole mannich bases to combat pain and allergic reactionsGRUENENTHAL GMBH·Filed 2000·Granted Apr 25, 2006·3 cites·93 claims
- 1866US8912189B2Pyridopyrazine derivatives and their useGERLACH MATTHIAS·Filed 2012·Granted Dec 16, 2014·1 cites·9 claims
- 1965US6774136B2Substituted 1 and 2 naphthol mannich basesGRUENENTHAL GMBH·Filed 2000·Granted Aug 10, 2004·2 cites·113 claims
- 2063US7375127B2Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs)AE ZENTARIS GMBH·Filed 2005·Granted May 20, 2008·1 cites·31 claims
- 2159US8507486B2Pyridopyrazine derivatives, process of manufacturing and uses thereofGERLACH MATTHIAS·Filed 2012·Granted Aug 13, 2013·0 cites·3 claims
- 2258US8604196B2Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thioureaGERLACH MATTHIAS·Filed 2012·Granted Dec 10, 2013·0 cites·21 claims
- 2353US7671074B2Sulfonylguanidine compounds and pharmaceutical uses thereofGRUENENTHAL GMBH·Filed 2007·Granted Mar 2, 2010·0 cites·18 claims
- 2452US7202242B2Substituted 1 and 2-naphthol Mannich basesGRUENENTHAL GMBH·Filed 2004·Granted Apr 10, 2007·0 cites·113 claims
- 2549US10200525B2Method and information system for informing a driver of a vehicle regarding the availability of a communication linkVOLKSWAGEN AG·Filed 2018·Granted Feb 5, 2019·0 cites·10 claims
- 2647US2003225084A1Sulfonylguanidine compounds and pharmaceutical uses thereofGRUENENTHAL GMBH·Filed 2003·Application pending·0 cites
- 2745US10623412B2Method for preventing deactivation of online services in a vehicleVOLKSWAGEN AG·Filed 2016·Granted Apr 14, 2020·0 cites·10 claims
- 2844US7199130B2Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonistsGRUENENTHAL GMBH·Filed 2004·Granted Apr 3, 2007·0 cites·49 claims
- 2943US10069959B2Method and information system for informing a driver of a vehicle regarding the availability of a communication linkVOLKSWAGEN AG·Filed 2016·Granted Sep 4, 2018·0 cites·11 claims
- 3043US7230103B2Substituted 3,4-dihydropyrido[1,2-a]pyrimidinesGRUENENTHAL GMBH·Filed 2003·Granted Jun 12, 2007·0 cites·14 claims
- 3143US7226924B2Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and useGRUENENTHAL GMBH·Filed 2003·Granted Jun 5, 2007·0 cites·18 claims
- 3243US2005009809A1Acridine derivatives and their use as medicamentsFiled 2004·Application pending·0 cites
- 3343US2008312301A1Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses ThereofGRUENENTHAL GMBH·Filed 2006·Application pending·0 cites
- 3441US2008051463A1Anthracene compounds and their use for treating benign and malignant tumor disordersAETERNA ZENTARIS GMBH·Filed 2007·Application pending·0 cites
- 3539US2004097734A1Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncosesFiled 2003·Application pending·0 cites
- 3636US6846843B2β-thioamino acidsGRUENENTHAL GMBH·Filed 2003·Granted Jan 25, 2005·0 cites·35 claims
- 3735US10841795B2Method and system for protected communication between a mobile unit coupled to a smartphone and a serverVOLKSWAGEN AG·Filed 2016·Granted Nov 17, 2020·0 cites·16 claims
- 3834US8394801B2Quinoxaline derivatives and their use for treating benign and malignant tumour disordersGERLACH MATTHIAS·Filed 2010·Granted Mar 12, 2013·0 cites·12 claims
- 3933US2016208298A1Enzymatic process for the regioselective manufacturing of n-fmoc-doxorubicin-14-o-dicarboxylic acid mono estersAETERNA ZENTARIS GMBH·Filed 2016·Application pending·0 cites
- 4033US2003236429A1Process for the production of chiral compoundsGRUENENTHAL GMBH·Filed 2003·Application pending·0 cites
- 4132US8546435B2Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptorsAICHER BABETTE·Filed 2011·Granted Oct 1, 2013·0 cites·6 claims
- 4230US8461178B2Naphthyridine derivatives and the use thereof as kinase inhibitorsSCHUSTER TILMANN·Filed 2010·Granted Jun 11, 2013·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Matthias Gerlach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →